Liquid Crystals: An Approach in Drug Delivery

被引:39
|
作者
Rajak, P. [1 ]
Nath, L. K. [1 ]
Bhuyan, B. [1 ]
机构
[1] Dibrugarh Univ, Dept Pharmaceut Sci, Dibrugarh 786004, Assam, India
关键词
Lyotropic liquid crystals; thermotropic liquid crystals; drug delivery; mesophases; cubic phase; WATER-SOLUBLE DRUG; IN-VITRO; SUSTAINED-RELEASE; ORAL DELIVERY; CUBIC PHASE; GLYCERATE SURFACTANTS; AMINO-ACIDS; NANOPARTICLES; SYSTEMS; BIOAVAILABILITY;
D O I
10.4172/pharmaceutical-sciences.1000474
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Liquid crystal systems are attracting significant attention due to their unique microstructures and physicochemical properties. Liquid crystals are becoming the choicest system for R and D professionals in the formulation development sector. Drug delivery to desired biological targets can effectively be achieved using liquid crystals system. Liquid crystalline phases are formed via three routes, the molecular shape, microsegregation effects and chirality. The objective of the present review was to provide information on different forms of liquid crystal systems along with unique physicochemical properties and possible utilization of the unique physicochemical properties of the systems in pharmaceutical formulation development. This review summarized characterization of liquid crystal mesophases highlighting the multidisciplinary application of liquid crystals in drug delivery with respect to cubic and hexagonal phases.
引用
收藏
页码:11 / 21
页数:11
相关论文
共 50 条
  • [1] Properties and Application of Nanostructure in Liquid Crystals: Review
    Smaisim, Ghassan Fadhil
    Mohammed, Khidhair Jasim
    Hadrawi, Salema K.
    Koten, Hasan
    Kianfar, Ehsan
    BIONANOSCIENCE, 2023, 13 (02) : 819 - 839
  • [2] Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals
    Rajabalaya, Rajan
    Musa, Muhammad Nuh
    Kifli, Nurolaini
    David, Sheba R.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 393 - 406
  • [3] Cubic and Hexagonal Liquid Crystals as Drug Delivery Systems
    Chen, Yulin
    Ma, Ping
    Gui, Shuangying
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [4] Liquid crystalline drug delivery vehicles for oral and IV/subcutaneous administration of poorly soluble (and soluble) drugs
    Otte, Andrew
    Soh, Bong-Kwan
    Yoon, Gwangheum
    Park, Kinam
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 539 (1-2) : 175 - 183
  • [5] The prospective of liquid crystals in nano formulations for drug delivery systems
    Bala, Rajni
    Sindhu, Rakesh K.
    Kaundle, Bharti
    Madaan, Reecha
    Cavalu, Simona
    JOURNAL OF MOLECULAR STRUCTURE, 2021, 1245
  • [6] Lyotropic liquid crystals for parenteral drug delivery
    Chavda, Vivek P.
    Dawre, Shilpa
    Pandya, Anjali
    Vora, Lalitkumar K.
    Modh, Dharti H.
    Shah, Vidhi
    Dave, Divyang J.
    Patravale, Vandana
    JOURNAL OF CONTROLLED RELEASE, 2022, 349 : 533 - 549
  • [7] Mesogenic Architectures for Advanced Drug Delivery: Interrogating Lyotropic and Thermotropic Liquid Crystals
    Govindan, Induja
    Paul, Angeeta
    Rama, Annamalai
    Kailas, Anjana A.
    Abutwaibe, K. A.
    Annadurai, Thamizharasan
    Naha, Anup
    AAPS PHARMSCITECH, 2024, 26 (01):
  • [8] Liquid crystal nanoparticles for commercial drug delivery
    Mo, J.
    Milleret, G.
    Nagaraj, M.
    LIQUID CRYSTALS REVIEWS, 2017, 5 (02) : 69 - 85
  • [9] pH-Responsive Lyotropic Liquid Crystals for Controlled Drug Delivery
    Negrini, Renata
    Mezzenga, Raffaele
    LANGMUIR, 2011, 27 (09) : 5296 - 5303
  • [10] Interactions of biomacromolecules with reverse hexagonal liquid crystals: Drug delivery and crystallization applications
    Libster, Dima
    Aserin, Abraham
    Garti, Nissim
    JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2011, 356 (02) : 375 - 386